Stoke Therapeutics, Inc.

STOK

—

Advanced chart & tools →

Stoke Therapeutics, Inc.STOK

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.12

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$184.42M

Net income

$-6.88M

Net margin

-3.7%

Gross margin

—

Dividends & financials

Stoke Therapeutics, Inc. (STOK) reported revenue of $184.42M and net income of $-6.88M, or $-0.12 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.